0000313143-14-000116.txt : 20141027
0000313143-14-000116.hdr.sgml : 20141027
20141027131652
ACCESSION NUMBER: 0000313143-14-000116
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141022
FILED AS OF DATE: 20141027
DATE AS OF CHANGE: 20141027
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HAEMONETICS CORP
CENTRAL INDEX KEY: 0000313143
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042882273
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0330
BUSINESS ADDRESS:
STREET 1: 400 WOOD RD
CITY: BRAINTREE
STATE: MA
ZIP: 02184
BUSINESS PHONE: 7818487100
MAIL ADDRESS:
STREET 1: 400 WOOD ROAD
CITY: BRAINTREE
STATE: MA
ZIP: 02184
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Burns Brian R
CENTRAL INDEX KEY: 0001312688
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14041
FILM NUMBER: 141174159
MAIL ADDRESS:
STREET 1: ONE BOSTON SCIENTIFIC PLACE
CITY: NATICK
STATE: MA
ZIP: 01760
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2014-10-22
0
0000313143
HAEMONETICS CORP
HAE
0001312688
Burns Brian R
400 WOOD ROAD
BRAINTREE
MA
02184
0
1
0
0
EVP, Global QA/RA
Common Stock
2014-10-22
4
A
0
3057.0
0.0
A
5534
D
Non-Qualified Stock Option (right to buy)
34.745
2014-10-22
4
A
0
13569.0
0.0
A
2014-10-22
2024-10-22
Common Stock
13569
13569
D
Performance Shares
0.0
2014-10-22
4
A
0
6115.0
0.0
A
2017-09-30
2017-12-31
Common Stock
6115
8599
D
Restricted Stock Unit Grant which vest 25% per year over 4 years following the grant date. Grant was made under 2005 Long Term Incentive Compensation Plan.
Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.
Performance Share Units represent a right to receive one share of Haemonetics Corporation common stock for each Performance Stock Unit based on the performance of Haemonetics stock price relative to the Standard & Poors Health Care Equipment Index. The number of Performance Stock Units (and therefore the number of shares payable) will depend on the Company's stock price performance between October 1, 2014 and September 30, 2017. The Performance Stock Units disclosed in column 5 represent a target amount. The number of shares ultimately issued could range from none to twice the target amount in column 5. The Performance Stock Units were granted under the 2005 Haemonetics Corporation Long-Term Incentive Compensation Plan and are exempt under Rule 16b-3(d).
By: Alexander Steffan For: Brian BUrns
2014-10-24